HUP0100214A3 - Ophthalmic composition containing quinazolin derivatives and their producing - Google Patents

Ophthalmic composition containing quinazolin derivatives and their producing

Info

Publication number
HUP0100214A3
HUP0100214A3 HU0100214A HUP0100214A HUP0100214A3 HU P0100214 A3 HUP0100214 A3 HU P0100214A3 HU 0100214 A HU0100214 A HU 0100214A HU P0100214 A HUP0100214 A HU P0100214A HU P0100214 A3 HUP0100214 A3 HU P0100214A3
Authority
HU
Hungary
Prior art keywords
producing
composition containing
ophthalmic composition
quinazolin derivatives
derivatives
Prior art date
Application number
HU0100214A
Other languages
English (en)
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of HUP0100214A2 publication Critical patent/HUP0100214A2/hu
Publication of HUP0100214A3 publication Critical patent/HUP0100214A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0100214A 1998-01-30 1999-01-29 Ophthalmic composition containing quinazolin derivatives and their producing HUP0100214A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1983698 1998-01-30
PCT/JP1999/000369 WO1999038497A2 (en) 1998-01-30 1999-01-29 Ophthalmic composition

Publications (2)

Publication Number Publication Date
HUP0100214A2 HUP0100214A2 (hu) 2002-02-28
HUP0100214A3 true HUP0100214A3 (en) 2002-10-28

Family

ID=12010371

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100214A HUP0100214A3 (en) 1998-01-30 1999-01-29 Ophthalmic composition containing quinazolin derivatives and their producing

Country Status (16)

Country Link
US (2) US6403598B1 (hu)
EP (2) EP1161942A3 (hu)
KR (1) KR20010040457A (hu)
CN (1) CN1295476A (hu)
AR (1) AR018272A1 (hu)
AT (1) ATE223219T1 (hu)
AU (1) AU2184499A (hu)
BR (1) BR9907715A (hu)
CA (1) CA2318516A1 (hu)
DE (1) DE69902738T2 (hu)
HU (1) HUP0100214A3 (hu)
IL (1) IL137128A0 (hu)
NO (1) NO20003786L (hu)
TR (1) TR200002209T2 (hu)
WO (1) WO1999038497A2 (hu)
ZA (1) ZA99733B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043015A1 (fr) * 1999-01-25 2000-07-27 Fujisawa Pharmaceutical Co., Ltd. Gouttes ophtalmologiques
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
US20060094643A1 (en) * 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
EP1757603A4 (en) * 2004-05-11 2008-06-25 Santen Pharmaceutical Co Ltd THERAPEUTIC AGENT FOR KERAATOCONJUNCTIVITIS AFFECTION
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
PE20100742A1 (es) * 2005-11-15 2010-11-25 Glaxo Group Ltd Nuevos procedimientos y formulaciones
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
WO2015095515A1 (en) * 2013-12-20 2015-06-25 Novartis Ag Sgc activators for the treatment of glaucoma
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
KR20200044873A (ko) 2017-08-24 2020-04-29 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 안구 제약학적 조성물
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
JPS6143114A (ja) * 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
JPH0782259A (ja) * 1993-09-14 1995-03-28 Senju Pharmaceut Co Ltd スクシンアミド酸誘導体及びそれを含有する糖尿病合併症治療剤

Also Published As

Publication number Publication date
BR9907715A (pt) 2000-10-17
CA2318516A1 (en) 1999-08-05
NO20003786D0 (no) 2000-07-24
ATE223219T1 (de) 2002-09-15
AR018272A1 (es) 2001-11-14
US20020161015A1 (en) 2002-10-31
KR20010040457A (ko) 2001-05-15
EP1004307B1 (en) 2002-09-04
DE69902738D1 (de) 2002-10-10
NO20003786L (no) 2000-07-24
HUP0100214A2 (hu) 2002-02-28
EP1161942A3 (en) 2003-12-10
IL137128A0 (en) 2001-07-24
AU2184499A (en) 1999-08-16
US6476039B1 (en) 2002-11-05
DE69902738T2 (de) 2003-02-06
EP1161942A2 (en) 2001-12-12
TR200002209T2 (tr) 2000-11-21
US6403598B1 (en) 2002-06-11
WO1999038497A2 (en) 1999-08-05
WO1999038497A3 (en) 2000-03-09
CN1295476A (zh) 2001-05-16
EP1004307A2 (en) 2000-05-31
ZA99733B (en) 1999-08-02

Similar Documents

Publication Publication Date Title
HUP0101172A3 (en) Ortho-anthranilamide derivatives and their use as anti-coagulants
ZA951458B (en) Quinazoline derivatives
HUS1400001I1 (hu) Kinazolin származékok, azok elõállítása, valamint a vegyületeket tartalmazó gyógyszerkészítmények
IL118825A (en) Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use
HUP0001154A3 (en) 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
GB9813271D0 (en) Composition and use
PL347357A1 (en) Novel composition and use
HUP0101320A3 (en) Benzo- and pyridobenzoxepine and -benzazepine derivatives and use thereof
GB9809143D0 (en) Triazine compounds and their use
HUP0100214A3 (en) Ophthalmic composition containing quinazolin derivatives and their producing
PL342008A1 (en) Benzothiadiazoles and their derivatives
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
IL139795A0 (en) Oxadiazoline derivatives and their use as insecticides
HK1041200A1 (zh) 化學化合物及其用途
GB9824335D0 (en) Mirror and method of making the same
GB2333774B (en) Oxopiperazinyl derivatives and light stabilized compositions
IL123535A0 (en) Benzoxazindione derivatives and their use
GB9814869D0 (en) Process and composition
EP1032559A4 (en) AMINO-ALKYLPHENOL DERIVATIVES AND ASSOCIATED COMPOUNDS
AU4629399A (en) Substituted piperazones and their therapeutic uses
IL113542A0 (en) Substituted hydroxybenzyl-heteroaryl derivatives compositions containing them and their use
IL118547A0 (en) Aqueous film-formimg compositions and their use
AU3171099A (en) 1-heteroindene derivatives and medicinal composition containing the same